[Effect of a compound preparation pumpan on exercise tolerance and clinical course of ischemic heart disease].
| Autor: | Krasnitskiĭ VB, Aronov DM, Zhidko NI |
|---|---|
| Jazyk: | ruština |
| Zdroj: | Terapevticheskii arkhiv [Ter Arkh] 2003; Vol. 75 (8), pp. 17-21. |
| Abstrakt: | Aim: To study effects of the drug pumpan on exercise tolerance and myocardial ischemia induced by exercise in patients with ischemic heart disease of functional class II-III. Material and Methods: The study included 30 patients with various forms of ischemic heart disease (myocardial infarction, coronary artery bypass grafting) having stable effort angina of functional class II-III. Results: The addition of a compound drug pumpan to a standard antianginal therapy reduced the number of anginal attacks and ST depression at bicycle exercise test. Conclusion: Pumpan is an adjuvant medication in conduction of antianginal therapy in ischemic heart disease patients with stable angina of effort of functional class II-III. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|